Literature DB >> 23371910

Decreased SPLUNC1 expression is associated with Pseudomonas infection in surgically treated chronic rhinosinusitis patients who may require repeated sinus surgery.

Yung-An Tsou1, Chuan-Mu Chen, Tzu-Chieh Lin, Fang-Wei Hu, Chin-Jann Tai, Hui-Chen Chen, Te-Huei Yeh, Horng-Jyh Harn, Ming-Hsui Tsai, Chia-Ing Jan.   

Abstract

OBJECTIVES/HYPOTHESIS: Chronic rhinosinusitis colonized with Pseudomonas aruginosa is difficult to treat and is related to biofilm formation. Repeated sinus surgery is often required for these patients. Short palate, lung, and nasal epithelial clone 1 (SPLUNC1) is an epithelium-secreted protein that is involved in innate immunity and has anti-Pseudomonas and antibiofilm functions. This study examined if SPLUNC1 expression was related to sinusitis with bacterial culture positive for Pseudomonas and the possibility of using SPLUNC1 to predict treatment outcomes for sinusitis. STUDY
DESIGN: Nonrandomized retrospective study.
METHODS: This was a retrospective study of patients at a tertiary referral center. Pseudomonas aruginosa infection was compared to clinical variables such as SPLUNC1 mRNA expression levels, immunohistochemical (IHC) stain intensity, Lund-Mackay sinus computed tomography scores, rapid recurrent sinusitis, requirement for repeat sinus surgery, Phadiatop test results, age, gender, nasal polyp(s), and patients' presence/absence of diabetes mellitus. Comparisons between groups were performed using the χ(2) test or Fisher exact test when one confronter was <5. The statistical analyses were carried out with SPSS version 13.
RESULTS: P. aeruginosa sinus infections were associated with lower sinus mucosa SPLUNC1 expression (P = .0018), weaker SPLUNC1 IHC staining intensity (P = .011), and poor postoperative outcome (i.e., need repeated sinus surgery) (P < .001). Other factors were not associated with Pseudomonas sinus infection.
CONCLUSIONS: Sinusitis with positive P. aeruginosa bacterial culture is associated with decreased SPLUNC1 sinus mucosa expression. Repeated sinus surgeries are more frequently needed for these patients.
Copyright © 2013 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23371910     DOI: 10.1002/lary.23871

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  10 in total

1.  Good's syndrome, CVID, and selective antibody deficiency in patients with chronic rhinosinusitis.

Authors:  Marianne Frieri
Journal:  Curr Allergy Asthma Rep       Date:  2014-06       Impact factor: 4.806

Review 2.  Bactericidal/Permeability-increasing protein fold-containing family member A1 in airway host protection and respiratory disease.

Authors:  Clemente J Britto; Lauren Cohn
Journal:  Am J Respir Cell Mol Biol       Date:  2015-05       Impact factor: 6.914

Review 3.  Chinese Society of Allergy and Chinese Society of Otorhinolaryngology-Head and Neck Surgery Guideline for Chronic Rhinosinusitis.

Authors:  Zheng Liu; Jianjun Chen; Lei Cheng; Huabin Li; Shixi Liu; Hongfei Lou; Jianbo Shi; Ying Sun; Dehui Wang; Chengshuo Wang; Xiangdong Wang; Yongxiang Wei; Weiping Wen; Pingchang Yang; Qintai Yang; Gehua Zhang; Yuan Zhang; Changqing Zhao; Dongdong Zhu; Li Zhu; Fenghong Chen; Yi Dong; Qingling Fu; Jingyun Li; Yanqing Li; Chengyao Liu; Feng Liu; Meiping Lu; Yifan Meng; Jichao Sha; Wenyu She; Lili Shi; Kuiji Wang; Jinmei Xue; Luoying Yang; Min Yin; Lichuan Zhang; Ming Zheng; Bing Zhou; Luo Zhang
Journal:  Allergy Asthma Immunol Res       Date:  2020-03       Impact factor: 5.764

4.  Structural Features Essential to the Antimicrobial Functions of Human SPLUNC1.

Authors:  William G Walton; Saira Ahmad; Michael S Little; Christine S K Kim; Jean Tyrrell; Qiao Lin; Y Peter Di; Robert Tarran; Matthew R Redinbo
Journal:  Biochemistry       Date:  2016-05-17       Impact factor: 3.162

5.  Interleukin-13 Inhibits Lipopolysaccharide-Induced BPIFA1 Expression in Nasal Epithelial Cells.

Authors:  Yung-An Tsou; Chia-Der Lin; Hui-Chen Chen; Hui-Ying Hsu; Lii-Tzu Wu; Chuan Chiang-Ni; Chih-Jung Chen; Tsu-Fang Wu; Min-Chuan Kao; Yu-An Chen; Ming-Te Peng; Ming-Hsui Tsai; Chuan-Mu Chen; Chih-Ho Lai
Journal:  PLoS One       Date:  2015-12-08       Impact factor: 3.240

6.  Evaluation of correlation of cell cycle proteins and Ki-67 interaction in paranasal sinus inverted papilloma prognosis and squamous cell carcinoma transformation.

Authors:  Yung-An Tsou; Hung-Jin Huang; Tang-Chuan Wang; Chih-Jaan Tai; Chuan-Mu Chen; Calvin Yu-Chian Chen
Journal:  Biomed Res Int       Date:  2014-06-12       Impact factor: 3.411

7.  Investigation of anti-infection mechanism of lactoferricin and splunc-1.

Authors:  Yung An Tsou; Hung-Jin Huang; Wesley Wen Yang Lin; Calvin Yu-Chian Chen
Journal:  Evid Based Complement Alternat Med       Date:  2014-04-30       Impact factor: 2.629

Review 8.  Modelling upper respiratory tract diseases: getting grips on host-microbe interactions in chronic rhinosinusitis using in vitro technologies.

Authors:  Charlotte De Rudder; Marta Calatayud Arroyo; Sarah Lebeer; Tom Van de Wiele
Journal:  Microbiome       Date:  2018-04-24       Impact factor: 14.650

Review 9.  The Role of BPIFA1 in Upper Airway Microbial Infections and Correlated Diseases.

Authors:  Yung-An Tsou; Min-Che Tung; Katherine A Alexander; Wen-Dien Chang; Ming-Hsui Tsai; Hsiao-Ling Chen; Chuan-Mu Chen
Journal:  Biomed Res Int       Date:  2018-09-03       Impact factor: 3.411

Review 10.  Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug-resistant Gram-negatives.

Authors:  María Escobar-Salom; Gabriel Torrens; Elena Jordana-Lluch; Antonio Oliver; Carlos Juan
Journal:  Biol Rev Camb Philos Soc       Date:  2022-01-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.